Article Text
Statistics from Altmetric.com
In his paper on page 518 of this issue, Dr Eric Nieman describes his medical journey of a progressive visual deterioration due to glaucoma, accompanied by the gradual development of increasingly distressing visual hallucinations - the Charles Bonnet syndrome.
The eponym was coined by de Morsier in the 1930s, in recognition of Charles Bonnet (1720–1793), a renowned Genoese naturalist, philosopher and biologist, who in 1769 described the hallucinatory experiences of his grandfather Charles Lullin, a 89-year-old magistrate. Lullin described his subjective perception of visions of people, animals, and buildings of various shapes and sizes, associated with visual deterioration after bilateral cataract surgery. He had normal cognition and realised his visions were ‘fictions’ of his brain.1
Charles Bonnet syndrome occurs predominantly in elderly, visually impaired people. Around 11%–15% experience complex visual hallucinations, whereas a significantly greater number, between 41%–59%, experience elementary visual phenomena. Such individuals do not have psychological or cognitive …
Footnotes
Contributors Sole author.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- Me and my neurological illness
Read the full text or download the PDF:
Other content recommended for you
- Disorders of visual perception
- Visual hallucinations and sight loss in children and young adults: a retrospective case series of Charles Bonnet syndrome
- Visual hallucinations
- Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
- Charles Bonnet syndrome in patients with Stargardt disease: prevalence and risk factors
- Benefit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome
- Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration
- Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19
- Negative outcome Charles Bonnet Syndrome
- Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre